ABCL vs GILD: Which Stock is Better?
Side-by-side comparison of Abcellera Biologics Inc and Gilead Sciences Inc in 2026
ABCL
Abcellera Biologics Inc
—
GILD
Gilead Sciences Inc
$132.16
Key Metrics Comparison
| Metric | ABCL | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.12B | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABCL
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABCL or GILD a better investment?
Comparing ABCL and GILD: Abcellera Biologics Inc has a market cap of $1.12B while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABCL and GILD?
ABCL (Abcellera Biologics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABCL or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABCL or GILD?
Both ABCL and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABCL or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABCL or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $1.12B for ABCL.
Should I buy ABCL or GILD in 2026?
Both ABCL and GILD have investment merit. ABCL trades at $N/A while GILD trades at $132.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABCL and GILD stock?
Key differences: Market Cap ($1.12B vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABCL or GILD in 2026?
The choice between ABCL and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABCL and GILD?
ABCL (Abcellera Biologics Inc) has a market cap of $1.12B, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.